A group of life sciences and bioinformatics companies have banded together in the race to find treatments, vaccines, and a cure for COVID-19. The fledgling EndPandemic National Data Consortium said last week that seven firms have signed on... Read More >

Envisagenics announced Tuesday it has entered into a research program agreement with Johnson Johnsons Lung Cancer Initiative (LCI.) Under the terms of the agreement, Envisagenics will build predictive models for lung cancer progression and... Read More >

Applied DNA Sciences said on Tuesday that it has partnered with Stony Brook University Hospital to validate the companys SARS-CoV-2 diagnostic. Called LineaCOVID-19, the test is designed to detect and quantify SARS-CoV-2 nucleic acid. Under... Read More >

The increasing number of original reference biologics coming off patent over the past few years is well known within the pharmaceutical industry with 17 coming off patent in Europe between 20182023 (1). The result is a substantial increase... Read More >

Although both share a preference for use of oral solid-dosage forms, the business model for consumer pharmaceutical manufacturersoften called over-the-counter (OTC) manufacturers in the United Statesdiffers significantly from that of prescr... Read More >

SPI Pharma has expanded its Mannogem mannitol product line for use in oral solid dosage (OSD) forms, offering a new Precious Gem Collection. Its goal is to address challenges that the crystalline sugar alcohol excipient poses for formulator... Read More >

4D pharma, a pharmaceutical company headquartered in the United Kingdom, announced on April 20, 2020 that it has received expedited acceptance from the UK Medicines and Healthcare products Regulatory Agency to launch a phase-II study of MRx... Read More >

Moderna, a clinical stage biotechnology company headquartered in Cambridge, MA, announced on April 16, 2020 that the Biomedical Advanced Research and Development Authority (BARDA), which is part of the US Department of Health and Human Serv... Read More >

The novel coronavirus pandemic has presented the global pharma industry with a double challenge:to develop potential treatments and preventative vaccines, and continue to meet the existing needs of healthcare providers and patients, all at... Read More >

Alnylam Pharmaceuticals, an RNA interference (RNAi) therapeutics company located in Cambridge, MA, and Blackstone Life Sciences, a private investment platform, announced on April 13, 2020 that they are entering into a strategic collaboratio... Read More >